Aspect Biosystems
PrivateLast Round
Grant
Apr 2, 2026
Total Funding Raised
$249.28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aspect Biosystems is a biotechnology company that develops a full-stack tissue therapeutic platform using proprietary AI-powered bioprinting technology to create implantable bioprinted tissue therapeutics for metabolic and endocrine diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspect Biosystems Comparables
Compare Aspect Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VoxCell BioInnovation | 84% | |
| Prellis Biologics | 84% | |
| Poietis | 83% |
Aspect Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2026 | ||||
| Series B | Jan 8, 2025 | ||||
| Grant | Jul 10, 2024 | ||||
| Grant | Mar 20, 2023 | ||||
| Series A | Jan 9, 2020 | ||||
Grant | Nov 15, 2018 |
Key People
Founding team and executive leadership
Aspect Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InBC Investment Corp. | Series B |
| Genome British Columbia | VC Round |
| Dimension | Series B |
| Government of British Columbia | Grant |
| Government of Canada | Grant |
| JDRF | Series B |
| Endure Capital | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM, reaching 13.6K.
- Apr 2, 2026
$57M grant funding secured.
Recent news
Latest coverage and updates
- is_developingJul 24, 2026
Aspect Biosystems Ltd. is developing cellular treatments for Type 1 diabetes.
Aspect Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aspect Biosystems's valuation, stock price, and market status.
Is Aspect Biosystems a public or private company?
Aspect Biosystems is a private company.
What is the current stock price of Aspect Biosystems?
Aspect Biosystems is a private company with no public stock price. No recent secondary market data is available.
How much is Aspect Biosystems worth (valuation)?
Valuation information for Aspect Biosystems is not publicly available.
Can I buy Aspect Biosystems stock?
Aspect Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aspect Biosystems's last funding round?
Aspect Biosystems's most recent funding round was Grant on April 2, 2026.
Who are the main investors in Aspect Biosystems?
Key investors in Aspect Biosystems include Dimension, Pangaea Ventures, Radical Ventures.
Will Aspect Biosystems IPO soon?
No public IPO plans have been announced for Aspect Biosystems.
How can I track Aspect Biosystems secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aspect Biosystems's secondary market activity and sign up for updates.